People who took Pfizer’s antiviral treatment Paxlovid shortly after infection saw a 26% lower risk of long Covid compared with those who didn’t, the study said.
Paxlovid is recommended for people over 50 or those with medical conditions such as high blood pressure or diabetes that place them at a greater risk of Covid.
){kind=link}
){kind=link}